User profiles for MATTHEW S. BLOCK

Matthew Block

Associate Professor of Oncology, Mayo Clinic
Verified email at mayo.edu
Cited by 3704

Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium

…, MA Davies, MC Andrews, DA Berry, MS Block… - The Lancet …, 2019 - thelancet.com
Advances in the treatment of metastatic melanoma have improved responses and survival.
However, many patients continue to experience resistance or toxicity to treatment, …

Dose-response association of CD8+ tumor-infiltrating lymphocytes and survival time in high-grade serous ovarian cancer

EL Goode, MS Block, KR Kalli, RA Vierkant… - JAMA …, 2017 - jamanetwork.com
Importance Cytotoxic CD8 + tumor-infiltrating lymphocytes (TILs) participate in immune control
of epithelial ovarian cancer; however, little is known about prognostic patterns of CD8 + …

[HTML][HTML] Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer

…, S Zawiah Omar, SH Olson, K Odunsi, S Nickels… - Nature …, 2013 - nature.com
HNF1B is overexpressed in clear cell epithelial ovarian cancer, and we observed epigenetic
silencing in serous epithelial ovarian cancer, leading us to hypothesize that variation in this …

Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer

…, P Haluska Jr, HJ Long, A Oberg, I Aderca, MS Block… - Cancer research, 2015 - AACR
Edmonston vaccine strains of measles virus (MV) have significant antitumor activity in
mouse xenograft models of ovarian cancer. MV engineered to express the sodium iodide …

IL10 release upon PD-1 blockade sustains immunosuppression in ovarian cancer

…, D Bahr, J Daum, KR Kalli, EL Goode, MS Block… - Cancer research, 2017 - AACR
Ligation of programmed cell death-1 (PD-1) in the tumor microenvironment is known to
inhibit effective adaptive antitumor immunity. Blockade of PD-1 in humans has resulted in …

Fate of Fixed Points with Monopoles

MS Block, RG Melko, RK Kaul - Physical review letters, 2013 - APS
We present an extensive quantum Monte Carlo study of the Néel to valence-bond solid (VBS)
phase transition on rectangular-and honeycomb-lattice SU (N) antiferromagnets in sign-…

The use of pembrolizumab for the treatment of metastatic uveal melanoma

…, RR McWilliams, SN Markovic, MS Block… - Melanoma …, 2016 - journals.lww.com
Uveal melanoma is a rare type of melanoma, with only five to seven cases per one million
persons diagnosed each year. Patients with metastatic melanoma of uveal origin tend to have …

[HTML][HTML] Th17-inducing autologous dendritic cell vaccination promotes antigen-specific cellular and humoral immunity in ovarian cancer patients

MS Block, AB Dietz, MP Gustafson, KR Kalli… - Nature …, 2020 - nature.com
In ovarian cancer (OC), IL-17-producing T cells (Th17s) predict improved survival, whereas
regulatory T cells predict poorer survival. We previously developed a vaccine whereby patient…

Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K+ channel

…, RA Vierkant, DN Rider, MS Block… - Human molecular …, 2013 - academic.oup.com
Ovarian cancer remains the leading cause of death in women with gynecologic malignancies,
despite surgical advances and the development of more effective chemotherapeutics. As …

First-in-class, first-in-human study evaluating LV305, a dendritic-cell tropic lentiviral vector, in sarcoma and other solid tumors expressing NY-ESO-1

N Somaiah, MS Block, JW Kim, GI Shapiro, KT Do… - Clinical Cancer …, 2019 - AACR
Purpose: LV305 is a modified, third-generation, nonreplicating, integration-deficient
lentivirus-based vector designed to selectively transduce dendritic cells in vivo. LV305 induces …